Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.29 Million | -13.97 Million | -25.86 Million | -30.21 Million | -17.19 Million | -13.63 Million |
| Net Income | -13.16 Million | -15.61 Million | -16.13 Million | -6.02 Million | -28.87 Million | -13.48 Million |
| Depreciation & Amortization | 984 Thousand | 479 Thousand | 1.04 Million | 662 Thousand | 194 Thousand | 154 Thousand |
| Deferred income taxes | -106 Thousand | - | -9.89 Million | -107 Thousand | 9.37 Million | -5.44 Million |
| Stock-based compensation | 717 Thousand | 1.1 Million | 1.54 Million | 2.04 Million | 2.28 Million | 1.55 Million |
| Change in working capital | -3.5 Million | 1.05 Million | -2.92 Million | -11.46 Million | 123 Thousand | 1.03 Million |
| Other non-cash items | -221 Thousand | -1 Million | 492 Thousand | -15.32 Million | -299 Thousand | 2.55 Million |
| Investing Cash Flow | -4.34 Million | 1.41 Million | 16.6 Million | 17.28 Million | -8.36 Million | -5.97 Million |
| Investments in PPE | -5000.00 | -72 Thousand | -1 Million | -2.33 Million | -1.47 Million | -250 Thousand |
| Acquisitions | 684 Thousand | 569 Thousand | -4.25 Million | 2.65 Million | 705 Thousand | 10 Thousand |
| Investment purchases | -7.52 Million | -569 Thousand | 25.14 Million | -1.29 Million | -28.35 Million | -29.88 Million |
| Sales/Maturities of investments | 2.5 Million | 569 Thousand | 21.84 Million | 18.25 Million | 21.45 Million | 24.15 Million |
| Other Investing Activities | -4.33 Million | 920 Thousand | -25.12 Million | 8000.00 | -689 Thousand | 10 Thousand |
| Financing Cash Flow | 5.51 Million | 4.51 Million | 21.9 Million | 20.56 Million | 21.98 Million | 22.47 Million |
| Debt repayment | - | -932 Thousand | -2.14 Million | -34 Thousand | -8000.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 10 Million |
| Common Stock Issuance | 5.51 Million | 5 Million | 23.29 Million | 8 Million | 17.5 Million | 22.47 Million |
| Other Financing Activities | 5.51 Million | 451 Thousand | 24.04 Million | 12.59 Million | 4.49 Million | 22.47 Million |
| Accounts receivables | 184 Thousand | 592 Thousand | -40 Thousand | -1.11 Million | -437 Thousand | 1.06 Million |
| Accounts payables | -522 Thousand | -757 Thousand | -372 Thousand | -580 Thousand | 2.1 Million | 176 Thousand |
| Inventory | -2.41 Million | 1.11 Million | -2.38 Million | -9.75 Million | -1.53 Million | 160 Thousand |
| Other working capital | -751 Thousand | 97 Thousand | -125 Thousand | -13 Thousand | -7000.00 | -365 Thousand |
| Cash at beginning of period | 20.64 Million | 28.68 Million | 16.04 Million | 8.41 Million | 11.99 Million | 9.12 Million |
| Cash at end of period | 6.51 Million | 20.64 Million | 28.68 Million | 16.04 Million | 8.41 Million | 11.99 Million |
| Capital Expenditure | -5000.00 | -72 Thousand | -1 Million | -2.33 Million | -1.47 Million | -250 Thousand |
| Effect of forex changes on cash | - | - | 2000.00 | - | - | - |
| Net cash flow / Change in cash | -14.12 Million | -8.04 Million | 12.64 Million | 7.62 Million | -3.58 Million | 2.87 Million |
| Free Cash Flow | -15.29 Million | -14.04 Million | -26.87 Million | -32.55 Million | -18.67 Million | -13.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.85 Million | -2.42 Million | -2.62 Million | -13.16 Million | -2.56 Million | 818 Thousand |
| Depreciation & Amortization | 17 Thousand | 228 Thousand | 222 Thousand | 984 Thousand | 89 Thousand | 67 Thousand |
| Deferred income taxes | - | - | -1.9 Million | -106 Thousand | -796 Thousand | -10.33 Million |
| Stock-based compensation | 102 Thousand | 138 Thousand | 144 Thousand | 717 Thousand | 162 Thousand | 199 Thousand |
| Change in working capital | -138 Thousand | -598 Thousand | -1.2 Million | -3.5 Million | -381 Thousand | -1.8 Million |
| Other non-cash items | -4.26 Million | 660 Thousand | 1.22 Million | -221 Thousand | 608 Thousand | 6.25 Million |
| Investing Cash Flow | 4.64 Million | 4000.00 | 52 Thousand | -4.34 Million | 5000.00 | -4.71 Million |
| Investments in PPE | -2 Million | -13 Thousand | -52 Thousand | -5000.00 | - | -5000.00 |
| Acquisitions | 145 Thousand | 17 Thousand | 73 Thousand | 684 Thousand | 5000.00 | 284 Thousand |
| Investment purchases | - | - | -2.52 Million | -7.52 Million | - | -5 Million |
| Sales/Maturities of investments | 2.5 Million | - | 2.5 Million | 2.5 Million | - | 5 Million |
| Other Investing Activities | 4 Million | 17 Thousand | 52 Thousand | -4.33 Million | 5000.00 | -4.99 Million |
| Financing Cash Flow | - | 5000.00 | -84.75 Million | 5.51 Million | 7000.00 | - |
| Debt repayment | - | - | -764 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -84.75 Million | - | - | - |
| Common Stock Issuance | - | 5000.00 | -7000.00 | 5.51 Million | 7000.00 | - |
| Other Financing Activities | - | 5000.00 | 771 Thousand | 5.51 Million | 7000.00 | - |
| Accounts receivables | -88 Thousand | -246 Thousand | -65 Thousand | 184 Thousand | 162 Thousand | 7000.00 |
| Accounts payables | 66 Thousand | -678 Thousand | -222 Thousand | -522 Thousand | -151 Thousand | - |
| Inventory | 137 Thousand | 303 Thousand | -1.03 Million | -2.41 Million | -72 Thousand | -1.27 Million |
| Other working capital | -253 Thousand | 23 Thousand | 109.99 Thousand | -751 Thousand | -320 Thousand | -532 Thousand |
| Cash at beginning of period | 3.31 Million | 6.51 Million | 10.61 Million | 20.64 Million | 13.48 Million | 22.99 Million |
| Cash at end of period | 5.5 Million | 3.31 Million | 6.51 Million | 6.51 Million | 10.61 Million | 13.48 Million |
| Capital Expenditure | -2 Million | -13 Thousand | -52 Thousand | -5000.00 | - | -5000.00 |
| Effect of forex changes on cash | - | - | 84.75 Million | - | - | -84.75 Million |
| Net cash flow / Change in cash | 2.18 Million | -3.2 Million | -4.09 Million | -14.12 Million | -2.87 Million | -9.51 Million |
| Free Cash Flow | -4.45 Million | -3.22 Million | -4.19 Million | -15.29 Million | -2.88 Million | -4.8 Million |
CTRI
NSFMF
7287
8103
603105
QCAAF